Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

5articles mentioning institutions

14institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: NCRAS ×

NCRAS

This institution is selected. Its supporting articles are shown below.

Articles mentioning NCRAS

5 articles · page 1 of 1

O77 External validation of an explainable survival machine learning model for pancreatic neuroendocrine tumours: a population-based study of 11,934 patients

gutjnl · abstract · 2026-06-23 · 5 matching annotations

91.0%

NCRAS SEER PanNET Pancreatic neuroendocrine tumours

…e (USA), and 3,612 patients (2012-2021) were extracted from the NCRAS database (England). Two Cox Survival XGBoost ML models were dev…

Inequalities in cancer diagnostic outcomes for patients with a learning disability: a retrospective cohort study in England

bmjonc · full text · 2026-05-18 · 4 matching annotations

87.0%

NCRAS Office for National Statistics breast cancer cancer

… (online supplemental table 2 for information on missing stage).NCRAS, National Cancer Registration and Analysis Service.Routes to di…

P167 Incidence trends and prognostic determinants of duodenal neuroendocrine neoplasms: comparative analysis of 6,002 patients from SEER (USA) and NCRAS (England)

gutjnl · abstract · 2026-06-23 · 2 matching annotations

92.5%

NCRAS SEER dNEN Neuroendocrine carcinoma

…e (USA), and 1,094 patients (2012-2021) were extracted from the NCRAS database (England). Average Annual Percent Change (AAPC) was ca…

Utilisation patterns of systemic anticancer therapy (SACT) in patients with advanced non-small cell lung cancer (NSCLC) in England

bmjonc · full text · 2026-05-21 · 2 matching annotations

82.0%

NICE NCRAS National Institute for Health and Care Excellence National Cancer Registration and Analysis Service lung cancer SACT

…ese findings suggest decisions about treatment may deviate from NICE guideline recommendations, although it is unclear to what exten…

P158 Faecal immunochemical test surveillance after gastroenteropancreatic neuroendocrine tumour diagnosis: real-world incidence of metachronous colorectal cancer in two national registries

gutjnl · abstract · 2026-06-23 · 1 matching annotations

78.7%

NCRAS SEER colorectal cancer GEP-NET gastroenteropancreatic neuroendocrine tumours metachronous second primary malignancies

… the England National Cancer Registration and Analysis Service (NCRAS) 2012–2021 and the US Surveillance, Epidemiology, and End Resul…